📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Better living through peptide-conjugated chemistry: next-generation antisense oligonucleotides. (2019)

First Author: McNally EM

Attributed to: Advanced peptide-oligonucleotide therapy for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci131933

PubMed Identifier: 31566581

Publication URI: http://europepmc.org/abstract/MED/31566581

Type: Journal Article/Review

Volume: 129

Parent Publication: The Journal of clinical investigation

Issue: 11

ISSN: 0021-9738